Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways

克拉斯 西妥昔单抗 蛋白激酶B PI3K/AKT/mTOR通路 癌症研究 Wnt信号通路 信号转导 结直肠癌 癌症 医学 内科学 生物 细胞生物学
作者
Yanfei Liu,Zhiqiang Feng,Tian-hao Chu,Ben Yi,Jun Liu,Haiyang Yu,Jun Xue,Yijia Wang,Chunze Zhang
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:126: 155462-155462 被引量:22
标识
DOI:10.1016/j.phymed.2024.155462
摘要

Cetuximab, an inhibitor targeting EGFR, is widely applied in clinical management of colorectal cancer (CRC). Nevertheless, drug resistance induced by KRAS-mutations limits cetuximab's anti-cancer effectiveness. Furthermore, the persistent activation of EGFR-independent AKT is another significant factor in cetuximab resistance. Nevertheless, the mechanism that EGFR-independent AKT drives cetuximab resistance remains unclear. Thus, highlighting the need to optimize therapies to overcome cetuximab resistance and also to explore the underlying mechanism. This work aimed to investigate whether and how andrographolide enhance the therapeutic efficacy of cetuximab in KRAS-mutant CRC cells by modulating AKT. The viabilities of CRC cell lines were analyzed by CCK-8. The intracellular proteins phosphorylation levels were investigated by Human Phospho-kinase Antibody Array analysis. Knockdown and transfection of PDGFRβ were used to evaluate the role of andrographolide on PDGFRβ. The western blotting was used to investigate Wnt/β-catenin pathways, PI3K/AKT, and EMT in KRAS-mutant CRC cells. The animal models including subcutaneous tumor and lung metastasis were performed to assess tumor response to therapy in vivo. Andrographolide was demonstrated to decrease the expression of PI3K and AKT through targeting PDGFRβ and EGFR, and it enhanced cetuximab effect on KRAS-mutant CRC cells by this mechanism. Meanwhile, andrographolide helped cetuximab to inhibit Wnt/β-catenin, CRC cell migration and reduced Vimentin expression, while increasing that of E-cadherin. Lastly, co-treatment with cetuximab and andrographolide reduced the growth of KRAS-mutant tumors and pulmonary metastases in vivo. Our findings suggest that andrographolide can overcome the KRAS-mutant CRC cells' resistance to cetuximab through inhibiting the EGFR/PI3K/AKT and PDGFRβ /AKT signaling pathways. This research provided a possible theory that andrographolide sensitizes KRAS-mutant tumor to EGFR TKI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐的应助被盒子采纳,获得10
刚刚
烟花的应助被卡乐瑞咩吹可采纳,获得10
1秒前
多多完成签到,获得积分10
1秒前
九三完成签到,获得积分10
1秒前
Tracer完成签到 ,获得积分10
1秒前
失眠煜祺发布了新的文献求助10
1秒前
山竹完成签到 ,获得积分10
2秒前
2秒前
可达鸭完成签到,获得积分10
2秒前
万万发布了新的文献求助10
3秒前
3秒前
滕亿年发布了新的文献求助10
3秒前
liu完成签到 ,获得积分10
4秒前
拂晨柳絮完成签到,获得积分10
4秒前
汉堡羊完成签到,获得积分10
4秒前
5秒前
6秒前
6秒前
豆芽菜发布了新的文献求助10
7秒前
lsk完成签到,获得积分20
7秒前
香蕉觅云的应助被刘婉敏采纳,获得10
7秒前
chiyudawang发布了新的文献求助10
8秒前
dashen完成签到,获得积分10
8秒前
9秒前
xiao完成签到,获得积分10
9秒前
deadzone完成签到,获得积分10
10秒前
nepdiana的应助被赤壁采纳,获得100
10秒前
李健的小迷弟的应助被万万采纳,获得10
10秒前
kcaj完成签到,获得积分0
11秒前
11秒前
zhuan发布了新的文献求助10
11秒前
12秒前
13秒前
miang发布了新的文献求助10
13秒前
xiao发布了新的文献求助10
13秒前
乐乐的应助被心晴采纳,获得10
13秒前
ljxx发布了新的文献求助10
13秒前
13秒前
14秒前
星辰大海的应助被夏尔酱采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178375
求助须知:如何正确求助?哪些是违规求助? 9569182
关于积分的说明 21802781
捐赠科研通 7773247
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556793
邀请新用户注册赠送积分活动 2478346